Andrew Krouse
Founder, President and CEO
Navion Neurosciences
Precision sodium-channel medicines for epilepsy and neuropathic pain
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Navion Neurosciences is a preclinical biotechnology company developing precision sodium-channel therapeutics for neurological diseases such as genetic epilepsies and chronic neuropathic pain. Its NaViGATion platform combines AI-enabled chemistry, structural biology, and ion-channel expertise. Headquartered at the Commonwealth Bio Accelerator in Charlottesville, Virginia. Public site: navionneuro.com.
- Website
- navionneuro.com
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- NaViGATion — AI-enabled discovery platform for sodium-channel medicines